HIRONIC

The HIRONIC Distributor Training program is back for its November schedule!Enrollment is now open, and we invite all our international distribution partners to join us in this comprehensive educational initiative.  As a leading manufacturer of cutting-edge skincare solutions, we recognize the crucial role our distributors play in delivering our products to customers worldwide.  This training program aims to empower your sales and marketing teams with the knowledge and skills necessary to effectively represent the HIRONIC brand and drive successful market penetration in your respective regions.  Our expert instructors will guide you through interactive sessions, hands-on demonstrations, and case studies.   

​On the evening of October 14, 2024, HIRONIC celebrated the grand launch of New Doublo 2.0 and PICOHI devices in collaboration with Optima Aesthetic at the Park Hyatt Bangkok’s Grand Ballroom. The event, attended by industry leaders and healthcare professionals, marked a significant milestone in HIRONIC's commitment to advancing medical aesthetics in Thailand.The launch was met with overwhelming interest from local stakeholders, reflecting the strong growth potential of the aesthetic medicine sector in Thailand. New Doublo 2.0, known for its precision and effectiveness, along with the innovative PICOHI, received enthusiastic reception, illustrating the demand for cutting-edge technologies in the local market.Throughout the night, attendees engaged in meaningful discussions, exploring the implications of these new technologies for their practices. The successful introduction of these devices has set the stage for their adoption across various clinics throughout Thailand, signaling a promising future for both HIRONIC and the Thai aesthetics industry.As we move forward, HIRONIC anticipates a fruitful partnership with Optima Aesthetic and looks forward to contributing to the dynamic growth of aesthetic medicine in Thailand.   

The 18th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!    

New Doublo 2.0™  presented at BODY ON TOP 2024.The live demonstration and hands-on workshop provided a practical insight into the 4th Generation HIFU + RF technology, highlighting its pain-free and swift treatment capabilities. We received lots of positive feedback from the doctors present, particularly impressed with the speed of treatment and the absence of pain during application. 

HIRONIC is excited to announce that our premier medical device, NEW DOUBLO 2.0, has successfully obtained medical device certification from Argentina's National Administration of Drugs, Food and Medical Technology (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica).This achievement opens significant opportunities for us to expand into the Argentine market, which boasts considerable economic potential. Argentina is anticipated to continue its steady economic growth in the coming years. These factors are expected to drive an increasing demand for medical services, creating an ideal environment for introducing our advanced medical solutions.We are thrilled to bring NEW DOUBLO 2.0 to such a dynamic and growing market, and we are committed to increasing our presence across South America, enhancing beautycare outcomes with our innovative technology.  

HIRONIC is committed to supporting our partners comprehensively. Recently, our team visited Vietnam to conduct hands-on training sessions with our most popular devices, the New Doublo 2.0 and Doublo Gold.   Over a two-day period, our trainers delivered one-on-one technical training and clinical education, sharing protocols and treatment expertise to ensure proficient use of our equipment.   Our dedicated Business Development team provides personalized communications about your products to ensure you achieve success through our support. We encourage you to take full advantage of the best-in-class training and educational opportunities included in our partnership.  ​

The 17th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     

HIRONIC has obtained approval from the Thai Food and Drug Administration (TFDA) on the 2nd of this month for its New Doublo2.0, a cutting-edge lifting device that incorporates both HIFU (MFU) and RF technologies. This device, equipped with advanced safety features, has already reached over 20 countries worldwide.The approval of New Doublo2.0 marks a significant step in strengthening HIRONIC's competitive edge in Thailand's medical aesthetics market. We are focused on expanding our sales and marketing efforts across Thailand and other Asian markets. Plans are underway to effectively communicate the product's capabilities through various initiatives targeted at local medical institutions and aesthetic professionals (key opinion leaders).These initiatives include exhibitions, academic programs, and hands-on training sessions. We also plan to continuously enhance the synergy between our upcoming new products by leveraging our high brand recognition and extensive local distribution networks.HIRONIC plans to further expand its sales and marketing initiatives to continue its leading position in Thailand, a major hub for beauty and cosmetic in Southeast Asia.​ 

The 16th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     

Dear Esteemed Key Opinion Leaders and Doctors,We are thrilled to announce an exclusive event.Join us on the 23rd of October for our BIG LAUNCH EVENT in Brazil. This gathering promises to be a landmark occasion, showcasing groundbreaking innovations and offering networking opportunities.We can't wait to unveil what we've been working on. Stay tuned for more details and get ready to be inspired!  

Dear Valued Partners and Clients,As someone who has been with HIRONIC from its inception, I am thrilled to continue our legacy of innovation and excellence in the aesthetic medical device industry. Our mission at HIRONIC has always been to enrich society and our customers’ welfare through innovative medical devices. We are dedicated to enhancing the quality of life for our users and expanding the possibilities within skin beauty technology.Looking ahead, we are committed to becoming the No.1 company in the global aesthetic medical device industry by 2030. We have set a clear vision to achieve the highest level of customer satisfaction and to elevate the quality of our services and products to the highest standards. These opportunities and challenges fill me with great anticipation.We will maintain the trust and confidence you have placed in us, and we are devoted to providing solutions that meet the evolving needs of our global customers. We are grateful for your ongoing partnership and support. Together, we will set new industry standards, ensuring that our products not only meet but exceed your expectations. We sincerely welcome your continuous advice and interest.Best regards, Jinu LeeCEO, HIRONIC 

We're excited to share a behind-the-scenes look at the preparations for our upcoming webinar and clinical sessions. Did you know that our New Doublo2.0 is not only revolutionary for facial lifting but also highly effective for body lifting and contouring? From basic principles to advanced techniques, our upcoming sessions will cover everything you need to know about utilizing New Doublo2.0's FL and SD for face and body lifting, as well as RM for rejuvenation and pigment treatment.Don’t miss out on these insightful sessions. Stay tuned and be ready to learn with us!   

We are announcing an exclusive distribution agreement with Ukrainian medical device distributor Under this agreement, Hironic will supply five types of products: 'Doublo Gold', 'Silkro', 'New Doublo 2.0', 'Picohi', and 'Ultra Vera', through the fourth quarter of 2026. 

 Hironic announced that it received import approval from the Central Drugs Standard Control Organization (CDSCO) of India for three of its medical devices: Doublo Gold ™, Ultra Vera ™, and Micool S™. A company spokesperson stated, "This approval opens the door for Hironic's medical devices to make a significant entry into the Indian market. Particularly, our HIFU product line had already been in demand by various buyers in India even before this approval. "In other developments, Hironic has reported an increase in exports in the first quarter of this year compared to the same period last year, indicating a significant expansion in the global market. From the second quarter, the company anticipates further expansion of its export volumes as its key products receive approvals in markets including Europe, Brazil, Peru, and Vietnam. 

Hironic has announced the commencement of exports to the Brazilian market following a strategic distribution agreement signed in June. The first order includes Hironic's flagship products: NEW DOUBLO 2.0™, SILKRO ™ (Total RF Solution), and PLASONIC ™. We express that this shipment marks the first entry of Hironic products into the Brazilian market following the acquisition of ANVISA certification, underscoring its significance. Considering the potential of the Brazilian aesthetic medical device market, the stature of Hironic products in the South American market, and their competitive quality and pricing, Hironic anticipates a sustained increase in exports to the South American markets.